ATE431819T1 - Nf-kb-inhibitoren und deren anwendungen - Google Patents
Nf-kb-inhibitoren und deren anwendungenInfo
- Publication number
- ATE431819T1 ATE431819T1 AT03731545T AT03731545T ATE431819T1 AT E431819 T1 ATE431819 T1 AT E431819T1 AT 03731545 T AT03731545 T AT 03731545T AT 03731545 T AT03731545 T AT 03731545T AT E431819 T1 ATE431819 T1 AT E431819T1
- Authority
- AT
- Austria
- Prior art keywords
- imidazolines
- agents
- treatment
- inflammatory
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/40—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38516202P | 2002-05-31 | 2002-05-31 | |
| US10/347,323 US6878735B2 (en) | 2002-05-31 | 2003-01-17 | Multi-substituted imidazolines and method of use thereof |
| PCT/US2003/017617 WO2003101954A2 (en) | 2002-05-31 | 2003-05-30 | Nf-kb inhibitors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE431819T1 true ATE431819T1 (de) | 2009-06-15 |
Family
ID=29715034
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03728735T ATE414062T1 (de) | 2002-05-31 | 2003-05-06 | Multisubstituierte imidazoline und verfahren zu deren anwendung |
| AT03731545T ATE431819T1 (de) | 2002-05-31 | 2003-05-30 | Nf-kb-inhibitoren und deren anwendungen |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03728735T ATE414062T1 (de) | 2002-05-31 | 2003-05-06 | Multisubstituierte imidazoline und verfahren zu deren anwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6878735B2 (de) |
| EP (2) | EP1532117B1 (de) |
| KR (1) | KR100723072B1 (de) |
| AT (2) | ATE414062T1 (de) |
| AU (2) | AU2003234507A1 (de) |
| CA (2) | CA2486836C (de) |
| DE (2) | DE60324684D1 (de) |
| ES (1) | ES2315497T3 (de) |
| WO (2) | WO2003101969A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080114015A1 (en) * | 2002-05-31 | 2008-05-15 | Board Of Trustees Of Michigan State University | NF-kB inhibitors and uses thereof |
| US7528161B2 (en) * | 2002-05-31 | 2009-05-05 | Michigan State University | NF-kappaB inhibitors and uses thereof |
| US6878735B2 (en) * | 2002-05-31 | 2005-04-12 | Board Of Trustees Of Michigan State University | Multi-substituted imidazolines and method of use thereof |
| US7345078B2 (en) * | 2002-05-31 | 2008-03-18 | The Board Of Trustees Of Michigan State University | NF-κB inhibitors and uses thereof |
| DE602005010401D1 (de) * | 2004-02-19 | 2008-11-27 | Solvay Pharm Bv | Imidazolinderivate mit cb1-antagonistischer wirkung |
| TWI335321B (en) * | 2004-02-19 | 2011-01-01 | Solvay Pharm Bv | Imidazoline derivatives having cb1-antagonistic activity |
| US7173044B2 (en) | 2004-02-19 | 2007-02-06 | Solvay Pharmaceuticals B.V. | Imidazoline derivatives having CB1-antagonistic activity |
| AU2006319248B2 (en) * | 2005-12-01 | 2012-09-27 | F.Hoffman-La Roche Ag | 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents |
| DE102005061430A1 (de) * | 2005-12-22 | 2007-07-05 | Grünenthal GmbH | Substituierte Imidazolin-Derivate |
| US8252942B2 (en) * | 2007-10-09 | 2012-08-28 | Board Of Trustees Of Michigan State University | Substituted imidazoline compounds |
| US8598346B2 (en) * | 2008-07-16 | 2013-12-03 | Bitop Ag | Synthesis of cyclic amidines |
| US9737510B2 (en) | 2013-07-31 | 2017-08-22 | Council Of Scientific & Industrial Research | Indazole compounds and a process for the preparation thereof |
| US20220380317A1 (en) | 2019-06-27 | 2022-12-01 | Nanyang Technological University | Compounds having antimalarial activity |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3354173A (en) * | 1964-04-16 | 1967-11-21 | Janssen Pharmaceutica Nv | Imidazole carboxylates |
| US5804374A (en) | 1980-12-05 | 1998-09-08 | Massachusetts Insti. Technology | Nuclear factors associates with transcriptional regulation |
| US6150090A (en) | 1986-01-09 | 2000-11-21 | Massachusetts Institute Of Technology | Nuclear factors associated with transcriptional regulation |
| US6001563A (en) | 1992-10-27 | 1999-12-14 | Queen's University At Kingston | Methods for identifying chemosensitizers |
| NZ327022A (en) * | 1996-01-26 | 1999-06-29 | Searle & Co | Heterocyclo-substituted imidazoles for the treatment of inflammation |
| US5821072A (en) | 1996-02-20 | 1998-10-13 | Sloan-Kettering Institute For Cancer Research | Combinations of PKC inhibitors and therapaeutic agents for treating cancers |
| US6123525A (en) | 1999-02-12 | 2000-09-26 | Coorstek, Inc. | Fluid pulsation stabilizer system and method |
| AU2002211662A1 (en) * | 2000-10-12 | 2002-04-22 | Smith Kline Beecham Corporation | Nf-kappab inhibitors |
| US7528161B2 (en) * | 2002-05-31 | 2009-05-05 | Michigan State University | NF-kappaB inhibitors and uses thereof |
| US6878735B2 (en) * | 2002-05-31 | 2005-04-12 | Board Of Trustees Of Michigan State University | Multi-substituted imidazolines and method of use thereof |
-
2003
- 2003-01-17 US US10/347,323 patent/US6878735B2/en not_active Expired - Lifetime
- 2003-05-06 DE DE60324684T patent/DE60324684D1/de not_active Expired - Lifetime
- 2003-05-06 AT AT03728735T patent/ATE414062T1/de not_active IP Right Cessation
- 2003-05-06 WO PCT/US2003/014169 patent/WO2003101969A1/en not_active Application Discontinuation
- 2003-05-06 EP EP03728735A patent/EP1532117B1/de not_active Expired - Lifetime
- 2003-05-06 AU AU2003234507A patent/AU2003234507A1/en not_active Abandoned
- 2003-05-06 CA CA2486836A patent/CA2486836C/en not_active Expired - Fee Related
- 2003-05-06 ES ES03728735T patent/ES2315497T3/es not_active Expired - Lifetime
- 2003-05-30 EP EP03731545A patent/EP1534686B1/de not_active Expired - Lifetime
- 2003-05-30 AU AU2003240533A patent/AU2003240533A1/en not_active Abandoned
- 2003-05-30 CA CA2486872A patent/CA2486872C/en not_active Expired - Fee Related
- 2003-05-30 WO PCT/US2003/017617 patent/WO2003101954A2/en not_active Application Discontinuation
- 2003-05-30 AT AT03731545T patent/ATE431819T1/de not_active IP Right Cessation
- 2003-05-30 KR KR1020047019054A patent/KR100723072B1/ko not_active IP Right Cessation
- 2003-05-30 DE DE60327700T patent/DE60327700D1/de not_active Expired - Lifetime
-
2005
- 2005-04-06 US US11/099,885 patent/US7652056B2/en not_active Expired - Fee Related
-
2010
- 2010-01-26 US US12/694,027 patent/US7858808B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6878735B2 (en) | 2005-04-12 |
| US20050192330A1 (en) | 2005-09-01 |
| US7858808B2 (en) | 2010-12-28 |
| AU2003240533A8 (en) | 2003-12-19 |
| DE60324684D1 (de) | 2008-12-24 |
| EP1534686A2 (de) | 2005-06-01 |
| WO2003101954A2 (en) | 2003-12-11 |
| ATE414062T1 (de) | 2008-11-15 |
| EP1532117A1 (de) | 2005-05-25 |
| ES2315497T3 (es) | 2009-04-01 |
| EP1532117B1 (de) | 2008-11-12 |
| CA2486836A1 (en) | 2003-12-11 |
| AU2003240533A1 (en) | 2003-12-19 |
| KR100723072B1 (ko) | 2007-05-29 |
| US20100204260A1 (en) | 2010-08-12 |
| CA2486836C (en) | 2012-02-07 |
| EP1534686B1 (de) | 2009-05-20 |
| US20030232870A1 (en) | 2003-12-18 |
| CA2486872C (en) | 2011-09-06 |
| WO2003101969A1 (en) | 2003-12-11 |
| DE60327700D1 (de) | 2009-07-02 |
| EP1534686A4 (de) | 2006-06-07 |
| WO2003101954A3 (en) | 2004-09-02 |
| US7652056B2 (en) | 2010-01-26 |
| EP1532117A4 (de) | 2006-05-10 |
| AU2003234507A1 (en) | 2003-12-19 |
| CA2486872A1 (en) | 2003-12-11 |
| KR20050004227A (ko) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE431819T1 (de) | Nf-kb-inhibitoren und deren anwendungen | |
| TR200401545T4 (tr) | NOSS inhibitörü ilaçların amalatı için ikame imidazo [1,2-a]piridin-,-pirimidin- ve-pirazin-3-amin-türevlerinin kullanımı | |
| CA2171637A1 (en) | Substituted Azaheterocyclecarboxylic Acids | |
| DK1104758T3 (da) | Acetylenderivativer som anti-inflammatoriske/analgesiske lægemidler | |
| AU5650901A (en) | Cyclohexane derivatives and their use as therapeutic agents | |
| CY1116393T1 (el) | Ετεροκυκλικοι αναστολεις της κινασης 3 του ιανου | |
| DE60135732D1 (de) | Topoisomerasehemmern zur behandlung von chirurgischen verklebungen | |
| DE60324544D1 (de) | Muskarin antagonisten | |
| DE69712900T2 (de) | Nitratester von corticoid verbindungen und die therapeutische verwendungen davon | |
| BRPI0114344B8 (pt) | composto retinóide, seu uso, sua composição farmacêutica e seu processo de preparação | |
| DE69332636D1 (de) | Antidepressiv und gegen die Parkinsonsche Krankheit wirkende Verbindungen | |
| BR9910058A (pt) | Compostos azapolicìclicos aril-condensados | |
| SE0203070D0 (en) | Novel compounds | |
| CO4410330A1 (es) | Nuevos derivados de bencimidazol farmacologicamente activos y sus sales de adicion acida | |
| EA200000204A1 (ru) | Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов | |
| WO2004041802A8 (en) | 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders | |
| AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
| ATE225787T1 (de) | Arylsubstituierte heterocyclische verbindungen | |
| ATE398614T1 (de) | Triazolverbindungen und ihre therapeutische verwendung | |
| DE602004020896D1 (de) | Neue dibenzoäb,füoxepin-10-carbonsäureamide und deren pharmazeutische anwendungen | |
| ATE263769T1 (de) | Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen | |
| SE0102639D0 (sv) | Novel compounds | |
| BR0308911A (pt) | Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto | |
| MXPA04005139A (es) | Derivados de 2 pirrolidin-2-il-iii-indol sustituidos para el tratamiento de migrana. | |
| HK1083839A1 (en) | Indoline compound and medicinal use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |